Commentary

D1.461 Overpayments

Corporate tax
Corporate tax | Commentary

D1.461 Overpayments

Corporate tax | Commentary

D1.461 Overpayments

Vaccine research tax credits were only payable to SMEs. As VRR for SMEs was repealed in relation to expenditure incurred on or after 1 April 2012, the following provisions only apply for expenditure incurred before 1 April 2012.

A mechanism has been provided to ensure excessive payments of the vaccine research tax credit may be recovered. This is achieved by adding the vaccine research tax credit to the scope of the existing rules that deal with recoveries of excessive repayments of tax and interest1.

To continue reading
View the latest version of this document, as well as thousands of others like it, sign in to TolleyLibrary or register for a free trial